Literature DB >> 6646296

Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples.

V Savica, G Bellinghieri, C Di Stefano, E Corvaja, F Consolo, M Corsi, F Maccari, L G Spagnoli, S Villaschi, G Palmieri.   

Abstract

The present study investigates 14 patients on intermittent haemodialysis. Pre-dialysis blood and muscle samples taken for determining plasma free- and acetylcarnitine levels. The tissue fragments were used for light and electron microscopy studies. Our results support the findings of other investigators that patients on haemodialysis generally display decreased free- and acetylcarnitine levels both in plasma and skeletal muscle when compared with control values. Muscle carnitine deficiency was apparently more severe in the longer-term haemodialysis patients. Moreover, a significant correlation (p less than 0.05) between plasma and muscle free-carnitine values was found. Morphologically no pathological alterations were observed in the muscle fibres in 13 of the patients. Light and electron microscopic studies of the muscle fibre of the 14th patient showed a typical nemaline myopathy with rod bodies in the cytoplasm. The muscle free-carnitine concentration in this patient was among the lowest of the group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6646296     DOI: 10.1159/000183087

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  14 in total

Review 1.  Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy.

Authors:  K N North; N G Laing; C Wallgren-Pettersson
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

Review 2.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

3.  Potential role of carnitine in patients with renal insufficiency.

Authors:  C Wanner; W H Hörl
Journal:  Klin Wochenschr       Date:  1986-07-01

Review 4.  Effect of uremia and its treatment on pulmonary function.

Authors:  D J Prezant
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 5.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

6.  A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production.

Authors:  D E Michele; F P Albayya; J M Metzger
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients.

Authors:  G E Moore; L A Bertocci; P L Painter
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Abnormally low serum acylcarnitine levels in narcolepsy patients.

Authors:  Taku Miyagawa; Hiroko Miyadera; Susumu Tanaka; Minae Kawashima; Mihoko Shimada; Yutaka Honda; Katsushi Tokunaga; Makoto Honda
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

9.  Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level.

Authors:  A E Grzegorzewska; I Mariak; A Dobrowolska-Zachwieja
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

10.  Influence of sex and chronic haemodialysis treatment on total, free and acyl carnitine concentrations in human serum.

Authors:  A S Alhomida; S H Sobki; M H al-Sulaiman; A A al-Khader
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.